Literature DB >> 8339250

Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma.

R J Weigel1, E C deConinck.   

Abstract

The mechanisms which control estrogen receptor (ER) expression in breast carcinoma have not been elucidated. The MCF-7 (ER-positive) and MDA-MB-231 (ER-negative) breast carcinoma cell lines have been used to examine ER gene expression. Northern blot analysis of mRNA isolated from these two cell lines demonstrates that MCF-7 cells express an expected 6.5-kilobase ER mRNA whereas MDA-MB-231 do not make detectable ER message. Reverse polymerase chain reaction, which offers greater sensitivity, confirms these Northern blot results. The nuclear run-on assay was used to examine directly transcription in these two cell lines. MCF-7 cells actively transcribe the ER gene whereas no ER transcription is detected in MDA-MB-231. Southern analysis of genomic DNA confirms that the ER gene is present in MDA-MB-231. We conclude that the ER gene is controlled transcriptionally in this ER-negative breast carcinoma line.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8339250

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  Analysis of estrogen receptor messenger RNA in breast carcinomas from archival specimens is predictive of tumor biology.

Authors:  C Carmeci; E C deConinck; T Lawton; D A Bloch; R J Weigel
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 2.  The epigenetics of breast cancer.

Authors:  Jovana Jovanovic; Jo Anders Rønneberg; Jörg Tost; Vessela Kristensen
Journal:  Mol Oncol       Date:  2010-04-29       Impact factor: 6.603

3.  A TFAP2C Gene Signature Is Predictive of Outcome in HER2-Positive Breast Cancer.

Authors:  Vincent T Wu; Boris Kiriazov; Kelsey E Koch; Vivian W Gu; Anna C Beck; Nicholas Borcherding; Tiandao Li; Peter Addo; Zachary J Wehrspan; Weizhou Zhang; Terry A Braun; Bartley J Brown; Vimla Band; Hamid Band; Mikhail V Kulak; Ronald J Weigel
Journal:  Mol Cancer Res       Date:  2019-10-16       Impact factor: 5.852

Review 4.  Neuroendocrine consequences of androgen excess in female rodents.

Authors:  Eileen M Foecking; Melissa A McDevitt; Maricedes Acosta-Martínez; Teresa H Horton; Jon E Levine
Journal:  Horm Behav       Date:  2008-01-10       Impact factor: 3.587

5.  A transcriptional enhancer required for the differential expression of the human estrogen receptor in breast cancers.

Authors:  Z Tang; I Treilleux; M Brown
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

6.  Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line.

Authors:  W W Kuang; D A Thompson; R V Hoch; R J Weigel
Journal:  Nucleic Acids Res       Date:  1998-02-15       Impact factor: 16.971

7.  Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells.

Authors:  George W Woodfield; Yizhen Chen; Thomas B Bair; Frederick E Domann; Ronald J Weigel
Journal:  Genes Chromosomes Cancer       Date:  2010-10       Impact factor: 5.006

8.  Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter.

Authors:  F De Amicis; S Zupo; M L Panno; R Malivindi; F Giordano; I Barone; L Mauro; S A W Fuqua; S Andò
Journal:  Mol Endocrinol       Date:  2009-01-15

9.  Transcriptional regulation of estrogen receptor in breast carcinomas.

Authors:  E C deConinck; L A McPherson; R J Weigel
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

10.  17beta-Oestradiol treatment modulates nitric oxide synthase activity in MDA231 tumour with implications on growth and radiation response.

Authors:  E C Chinje; K J Williams; B A Telfer; P J Wood; A J van der Kogel; I J Stratford
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.